CIK 0001625101 · Non-accelerated filer<br>Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465696597
- Phone
- 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- Open-market buys, last 90 days
- $199,937
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$199,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-12 | UECKER DARRIN Chief Technology Officer | Sale | −15,000 | $16.40 | $246K | 137,872 |
| 2025-02-03 | Skinner Jon Chief Financial Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2025-02-03 | Zanganeh Mahkam Director | Option exercise | +30,121 | $11.00 | $331K | 725,395 |
| 2025-02-03 | Zanganeh Mahkam Director | Option exercise · Warrant (right to buy) | −30,121 | 0 | ||
| 2025-01-24 | Zanganeh Mahkam Director | Option exercise | +30,121 | $11.00 | $331K | 695,274 |
| 2025-01-24 | Zanganeh Mahkam Director | Option exercise · Warrant (right to buy) | −30,121 | 0 | ||
| 2025-01-09 | LAVIOLETTE PAUL A Chief Executive Officer | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 | ||
| 2025-01-09 | LAVIOLETTE PAUL A Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,050,000 | 1,050,000 | ||
| 2024-12-18 | DUGGAN ROBERT W Director | Option exercise | +5,187,824 | $11.00 | $57.1M | 47,516,541 |
| 2024-12-18 | DUGGAN ROBERT W Director | Option exercise | +69,020 | $11.00 | $759K | 630,109 |
| 2024-12-18 | DUGGAN ROBERT W Director | Option exercise | +49,312 | $11.00 | $542K | 450,189 |
| 2024-12-18 | DUGGAN ROBERT W Director | Option exercise · Warrants (right to buy) | −2,593,912 | 0 | ||
| 2024-12-18 | DUGGAN ROBERT W Director | Option exercise · Warrants (right to buy) | −2,593,912 | 0 | ||
| 2024-12-18 | DUGGAN ROBERT W Director | Option exercise · Warrants (right to buy) | −34,510 | 0 | ||
| 2024-12-18 | DUGGAN ROBERT W Director | Option exercise · Warrants (right to buy) | −34,510 | 0 | ||
| 2024-12-18 | DUGGAN ROBERT W Director | Option exercise · Warrants (right to buy) | −24,656 | 0 | ||
| 2024-12-18 | DUGGAN ROBERT W Director | Option exercise · Warrants (right to buy) | −24,656 | 0 | ||
| 2024-12-13 | DUGGAN ROBERT W Director | Purchase | +55,256 | $17.18 | $949K | 42,328,717 |
| 2024-12-12 | DUGGAN ROBERT W Director | Purchase | +45,404 | $17.13 | $778K | 42,273,461 |
| 2024-12-11 | Barrett Burke Thomas Former President and CEO | Sale | −50,000 | $17.42 | $871K | 63,172 |
Page 5 of 15 · 292 trades